Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Xian Zhou"'
Autor:
Xiaoxue Liu, Jianrui Li, Qiang Xu, Qirui Zhang, Xian Zhou, Hao Pan, Nan Wu, Guangming Lu, Zhiqiang Zhang
Publikováno v:
Cancers; Volume 14; Issue 12; Pages: 2818
Rs-fMRI can provide rich information about functional processes in the brain with a large array of imaging parameters and is also suitable for investigating the biological processes in cerebral gliomas. We aimed to propose an imaging analysis method
Autor:
Xianjin Zhou, Sha Tian, Xian Zhou, Huimin Shi, Yi Li, Jianjiang Xiao, Kun Chen, Bobin Chen, Gezhi Xu, Qingping Wang
Publikováno v:
Cancer Management and Research.
Xianjin Zhou,1â 3 Sha Tian,3 Xian Zhou,3 Huimin Shi,3 Yi Li,3 Jianjiang Xiao,3 Kun Chen,4 Bobin Chen,5 Gezhi Xu,1,2 Qingping Wang3 1Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, Peopleâs Republic of C
Autor:
Wencong Ding, Xian Zhou, Guoqiang Jiang, Weiwei Xu, Songkai Long, Fan Xiao, Yongshi Liao, Jia Liu
Publikováno v:
Journal of Oncology.
Background. Glioblastoma (GBM) is the most malignant of all known intracranial tumors; meanwhile, most patients have a poor prognosis. In order to improve the poor prognosis of GBM patients as much as possible, it is specifically significant to ident
Autor:
Wei Dong Zang, Rui Zhao, Bo Dai, Jian-Yuan Zhao, Shu Xian Zhou, Qian Zhou, Guo Hai Shi, Fu Jiang Xu, Xuan Zhang, Yi Jun Shen, Yuan-Yuan Qu, Wenhao Xu, Hai Liang Zhang, Yao Zhu, Wei Xu, Yan Lin, Yiping Zhu, Kun Chang, Ning Shao, Cheng Tao Han, Dingwei Ye, Shimin Zhao
Publikováno v:
Cancer Research. 80:319-333
The tumorigenic role and underlying mechanisms of lipid accumulation, commonly observed in many cancers, remain insufficiently understood. In this study, we identified an AMP-activated protein kinase (AMPK)–GATA-binding protein 3 (GATA3)–enoyl-Co
Autor:
Ahmad Rizal Ganiem, James A Seddon, Ursula K. Rohlwink, Xian Zhou, Rovina Ruslami, Regan Solomons, Suzaan Marais, Fiona V Cresswell, Wenhong Zhang, Reinout van Crevel, Feng Sun, Elizabeth W. Tucker, Jo M. Wilmshurst
Publikováno v:
Open Forum Infectious Diseases, 7, 11
Open Forum Infectious Diseases, 7
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 7
Open Forum Infectious Diseases
Background Tuberculous meningitis (TBM) is a medical emergency, yet there are no standardized treatment guidelines for the medical or neurosurgical management of these patients and little data on neurocritical care. We conducted an international surv
Autor:
Wen-jun Xiao, Fu-jiang Xu, Xuan Zhang, Shu-xian Zhou, Hai-liang Zhang, Bo Dai, Yao Zhu, Guo-hai Shi, Yi-jun Shen, Yi-ping Zhu, Yuan-yuan Qu, Jian-yuan Zhao, Ding-wei Ye
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
Objective: To investigate the association between tumor PD-L1 expression and patient survival to determine whether PD-L1 represents an independent prognostic feature for patients with non-metastatic clear cell renal cell carcinoma (RCC). Patients and
Publikováno v:
Molecular Medicine Reports
Platelet-activating factor (PAF) promotes glomerular extracellular matrix (ECM) deposition, primarily through activation of the protein kinase C (PKC) pathway. The present study was designed to investigate whether atorvastatin, which mediates a prote
Autor:
Edward Gabrielson, Xian Zhou, Christine L. Hann, Julie R. Brahmer, Gary L. Rosner, Barbara Coleman, Ronan J. Kelly, Michael Purtell, Patrick M. Forde, David S. Ettinger, Kristen A. Marrone
Publikováno v:
The Oncologist
Background In the absence of a targeted oncogenic driver mutation or high programmed death-ligand 1 expression, systemic therapy with platinum-based doublet chemotherapy with or without bevacizumab has been the standard treatment in advanced or metas
Autor:
KE Reeder-Hayes, Stephanie B. Wheeler, Christopher D. Baggett, Xian Zhou, A-M Meyer, MC Roberts, Ke Meng
Publikováno v:
Cancer Research. 78:P4-10
Gene expression profile (GEP) testing in early hormone receptor-positive (HR+) breast cancer can inform adjuvant treatment decisions by providing refined estimates of prognosis and chemotherapy benefit. GEPs may also downshift chemotherapy use, poten